Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.

• Главные авторы: Shyam Sundar (Автор), Krishna Pandey (Автор), Chandreshwar Prasad Thakur (Автор), Tara Kant Jha (Автор), Vidya Nand Ravi Das (Автор), Neena Verma (Автор), Chandra Shekhar Lal (Автор), Deepak Verma (Автор), Shahnawaz Alam (Автор), Pradeep Das (Автор)
• Формат: ‌
• Опубликовано: Public Library of Science (PLoS), 2014-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The authors evalu...